Patents Assigned to Boston Scientific Neuromodulation Corporation
  • Patent number: 11565117
    Abstract: Improved stimulation circuitry for controlling the stimulation delivered by an implantable stimulator is disclosed. The stimulation circuitry includes memory circuitry that stores pulse programs that define pulse shapes, steering programs that define electrode configurations, and aggregate programs that link a selected pulse program with a selected steering program. The aggregate programs also include an amplitude modulation factor that modulates the amplitude defined by the pulse program. The inclusion of an amplitude modulation factor in the aggregate program allows complex amplitude-modulated waveforms to be produced. Pulse definition circuits in the stimulation circuitry execute aggregate programs to generate stimulation waveforms, which stimulation waveforms can be generated simultaneously by the different pulse definition circuits.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: January 31, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Philip Leonard Weiss, Pujitha Weerakoon, David Michael Wagenbach
  • Patent number: 11565116
    Abstract: An example of a system for delivering neurostimulation energy may include a programming control circuit and a user interface. The programming control circuit may be configured to generate stimulation parameters according to a neurostimulation program including a pattern of interferential stimulation configured to effect asynchronous and/or non-regular activation of nerve fibers by simultaneously delivering a first stimulation current having a first waveform with a first frequency using a first electrode configuration and a second stimulation current having a second waveform with a second frequency using a second electrode configuration.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: January 31, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Tianhe Zhang, Joseph M. Bocek, Rosana Esteller
  • Patent number: 11565131
    Abstract: An optical stimulation system includes a light source; an optical lead coupled, or coupleable, to the light source; at least one of a calibration table or a calibration formula, generated by a calibration procedure specifically using the light source and the optical lead of the optical stimulation system; and a control unit coupled, or coupleable, to the light source. The control module includes a memory to store the at least one of the calibration table or the calibration formula, and a processor coupled to the memory and configured for receiving a target light output level, using the at least one of the calibration table or the calibration formula to determine at least one operational parameter for generating the target light output level, and directing the light source, using the at least one operational parameter, to generate light at the target light output level.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: January 31, 2023
    Assignees: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (“CEA”)
    Inventors: Dennis Allen Vansickle, Adam Thomas Featherstone, Claude Chabrol, Michael A. Moffitt, Sarah Renault, Adrien Poizat
  • Patent number: 11565114
    Abstract: An example of a system may include a processor, and a memory device comprising instructions, which when executed by the processor, cause the processor to access at least one of patient input, clinician input, or automatic input, use the patient input, clinician input, or automatic input in a search method, the search method designed to evaluate a plurality of candidate neuromodulation parameter sets to identify an optimal neuromodulation parameter set, and program a neuromodulator using the optimal neuromodulation parameter set to stimulate a patient.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: January 31, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Christopher Ewan Gillespie, Michael A. Moffitt, Que T. Doan, Changfang Zhu
  • Patent number: 11559355
    Abstract: A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: January 24, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Elizabeth M. Annoni, Bryan A. Clark, Dennis Zottola, Kyle H. Srivastava, Jonathan B. Shute
  • Patent number: 11559693
    Abstract: Techniques for pairing an external device such as a clinician programmer (CP) to an implantable medical device (IMD) are disclosed, which involve use of a remote controller (RC) paired to the IMD. The RC is placed into a CP pairing mode, which acts differently depending on the type of IMD paired to the RC. If the IMD is RF based, the CP pairing mode places the IMD in a pairing mode, thus allowing the CP to connect directly with the IMD via a RF telemetry protocol. If the IMD is magnetic-induction based, the CP pairing mode causes the RC to advertise its presence to the CP, allowing the CP to connect to the RC via the RF telemetry protocol. Because the RC is also paired with the IMD via a magnetic induction telemetry protocol, the RC acts as a passthrough device to allow communications between the CP and the IMD.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: January 24, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Chirag Shah, Peter Yoo
  • Patent number: 11547861
    Abstract: A system may be used with a medical imaging system and a programming system. The medical imaging system may be configured to display a medical image and the programming system may be configured to implement a program used in programming a neuromodulation device. The system may comprise a mobile device having at least one processor, a camera and a user interface including a display. The mobile device may be configured to acquire a displayed medical image from the medical imaging system, determine based on the acquired medical image location data indicative of the position of at least one of the electrodes relative to at least one of the anatomy or at least another one of the electrodes, and provide the location data for use by the program implemented by the programming system.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: January 10, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Ismael Huertas Fernandez, Matthew Lee McDonald, Amarpreet Singh Bains, Anirudh Joshi
  • Patent number: 11541240
    Abstract: This document discusses, among other things, systems and methods for managing pain of a subject. A system includes one or more physiological sensors configured to sense a physiological signal indicative of patient brain activity. The physiological signals may include an electroencephalography signal, a magnetoencephalography signal, or a brain-evoked potential. The system may extract from the brain activity signal one or more signal metrics indicative of strength or pattern of brain electromagnetic activity associated with pain, and generate a pain score using the one or more signal metrics. The pain score can be output to a patient or a process. The system may select an electrode configuration for pain-relief electrostimulation based on the pain score, and deliver a closed-loop pain therapy according to the selected electrode configuration.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: January 3, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Elizabeth Mary Annoni, Jianwen Gu, Rosana Esteller, Bryan Allen Clark, Pramodsingh Hirasingh Thakur, Kyle Harish Srivastava
  • Patent number: 11529510
    Abstract: A lead introducer includes an integrated sheath/needle including a splittable sheath configured to split a into a first portion and a second portion, a needle having a length and a proximal end region, and a hub coupled to the proximal end regions of the splittable sheath and the needle and configured to split into a first portion and a second portion. The needle is permanently attached to either the first portion of the hub or the first portion of the splittable sheath (or both) so that when the hub is split into the first and second portions, the needle remains attached to the first portion of the hub or the first portion of the splittable sheath.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: December 20, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Jacob B. Leven
  • Patent number: 11524163
    Abstract: A neuromodulation system and method of providing sub-threshold modulation therapy. Electrical modulation energy is delivered to a target tissue site of the patient at a programmed intensity value, thereby providing therapy to a patient without perception of stimulation. In response to an event, electrical modulation energy is delivered at incrementally increasing intensity values. At least one evoked compound action potential (eCAP) is sensed in a population of neurons at the target tissue site of the patient in response to the delivery of the electrical modulation energy at the incrementally increasing intensity values. One of the incrementally increased intensity values is selected based on the sensed eCAP(s). A decreased intensity value is automatically computed as a function of the selected intensity value. Electrical modulation energy is delivered to the target tissue site of the patient at the computed intensity value, thereby providing sub-threshold therapy to the patient.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: December 13, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Tamara C. Baynham, Jordi Parramon
  • Patent number: 11524174
    Abstract: An optical stimulation system includes a light source configured to produce light for optical stimulation; a light monitor; an optical lead coupled, or coupleable, to the light source and the light monitor; and a control module coupled, or coupleable, to the light source and the light monitor. The control module includes a memory, and a processor coupled to the memory and configured for receiving a request for verification or measurement of a light output value; in response to the request, receiving, from the light monitor, a measurement of light generated by the light source; and, based on the measurement, reporting a response to the request.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: December 13, 2022
    Assignees: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, COMMISSARIAT Â L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (“CEA”)
    Inventors: Dennis Allen Vansickle, Adam Thomas Featherstone, John Rivera, Claude Chabrol, Sarah Renault, Adrien Poizat, Michael A. Moffitt
  • Patent number: 11517755
    Abstract: An example of a system for delivering neurostimulation may include a programming control circuit and a stimulation control circuit. The programming control circuit may be configured to generate stimulation parameters controlling delivery of the neurostimulation according to a stimulation configuration. The stimulation control circuit may be configured to specify the stimulation configuration, and may include volume definition circuitry and stimulation configuration circuitry. The volume definition circuitry may be configured to determine one or more test volumes, determine a clinical effect resulting from the one or more test volumes each being activated by the neurostimulation, and determine a target volume using the determined clinical effect. The stimulation configuration circuitry may be configured to generate the specified stimulation configuration for activating the target volume.
    Type: Grant
    Filed: December 30, 2020
    Date of Patent: December 6, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Tianhe Zhang, Michael A. Moffitt, Richard Mustakos, Stephen Carcieri
  • Patent number: 11511127
    Abstract: An optical stimulation lead includes a lead body including a distal end, a distal portion, and a proximal portion; and an optical assembly attached to the distal end of the lead body. The optical assembly includes a light emitter; a feedthrough assembly including at least one ceramic block, at least one feedthrough pin extending through the at least one ceramic block and electrically coupled to the light emitter, and a metal housing attached to the at least one ceramic block; a metal tube attached to the feedthrough assembly and disposed around the light emitter; and an emitter cover disposed over the light emitter and coupled to the metal tube.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: November 29, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: William George Orinski
  • Patent number: 11504526
    Abstract: An electrical stimulation system includes at least one electrical stimulation lead, each of the at least one electrical stimulation lead including a plurality of stimulation electrodes; and a processor coupled to the lead and configured to perform actions, including: directing delivery of at least one electrical pulse through at least one of the stimulation electrodes of the at least one electrical stimulation lead to tissue of a patient; and directing discrete or intermittent measurement of an electrical characteristic of the tissue using at least one of the stimulation electrodes of the at least one electrical stimulation lead during, and after, delivery of the at least one electrical pulse to the tissue of the patient.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: November 22, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Changfang Zhu
  • Patent number: 11504539
    Abstract: An example of a neurostimulation system may include a storage device for storing data representing physiological signals and a user interface including a user input, a display screen, and a presentation control circuit. The user input may be configured to receive a selection of signal(s) from the physiological signals and a selection of viewing mode from viewing modes including a metric mode and/or a presence mode. The metric mode allows for visualization of a signal property indicated by a parameter measured from the selected signal(s). The presence mode allows for viewing presence of a feature in the selected signal(s). The presentation control circuit may be configured to allow for the selection of the signal(s) and the viewing mode, to determine a segment of each of the selected signal(s) for presentation according to the selected viewing mode, and to present the determined segment on the display screen.
    Type: Grant
    Filed: August 11, 2020
    Date of Patent: November 22, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Tianhe Zhang, Rosana Esteller
  • Patent number: 11497917
    Abstract: A method of stimulating nerve tissue, a tissue stimulation system, and an external control device are provided. The method, system, and control device causes an electrical stimulus to be applied to at least one electrode adjacent the nerve tissue of a patient. The applied electrical stimulus comprises a plurality of pulses defined by a pulse width value and an amplitude value. The pulse amplitude value is increased (e.g., manually), and the pulse width value is automatically decreased in response to increasing the pulse amplitude value in a manner that increases the intensity of the applied electrical stimulus. Alternatively, the pulse width value may be decreased (e.g., manually), and the pulse amplitude value automatically increased in response to decreasing the pulse width value in a manner that increases the intensity of the applied electrical stimulus.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: November 15, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Kerry Bradley, Bradley Lawrence Hershey, Dongchul Lee
  • Patent number: 11497914
    Abstract: A control module for an electrical stimulation system includes a sealed electronics housing; an electronic subassembly disposed within the electronics housing; one or more connector assemblies coupled to the electronic subassembly; and a rechargeable battery disposed external to the electronics housing. The one or more connector assemblies are configured to receive a lead. The rechargeable battery includes a positive electrode, a negative electrode, and a single battery case attached directly to the sealed electronics housing and forming a sealed cavity that encapsulates both the positive electrode and the negative electrode. The battery case is electrically isolated from each of the positive electrode and the battery electrode.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: November 15, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Benjamin Phillip Hahn, David M. Dorman
  • Patent number: 11471684
    Abstract: Systems and techniques are disclosed to generate programming parameters and modifications during closed-loop adjustment of an implantable neurostimulation device treatment programming, through the identification and application of weights determined from user input indications and rankings of therapy objectives.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: October 18, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Matthew Lee McDonald
  • Patent number: 11471692
    Abstract: A charging system for an Implantable Medical Device (IMD) is disclosed having a charging coil and one or more sense coils preferably housed in a charging coil assembly coupled to an electronics module by a cable. The charging coil is preferably a wire winding, while the sense coils are preferably formed in one or more traces of a circuit board. One or more voltages induced on the one or more sense coils can be used to determine one or more parameters (magnitude, phase angle, resonant frequency) indicative of the position between the charging coil and the IMD, which position may include the radial offset and possibly also the depth of the charging coil relative to the IMD. Knowing the position, the power of the magnetic field produced by the charging coil can be adjusted to compensate for the position.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: October 18, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Daniel Aghassian, Thomas W. Stouffer, Jonathan Larcom, Gaurav Gupta
  • Patent number: 11452873
    Abstract: A current generation architecture for an implantable stimulator device such as an Implantable Pulse Generator (IPG) is disclosed. Current source and sink circuitry are both divided into coarse and fine portions, which respectively can provide coarse and fine current resolutions to a specified electrode on the IPG. The coarse portion is distributed across all of the electrodes and so can source or sink current to any of the electrodes. The coarse portion is divided into a plurality of stages, each of which is capable via an associated switch bank of sourcing or sinking a coarse amount of current to or from any one of the electrodes on the device. The fine portion of the current generation circuit preferably includes source and sink circuitry dedicated to each of the electrode on the device, which can comprise digital-to-analog current converters (DACs).
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: September 27, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jordi Parramon, David K. L. Peterson, Paul J. Griffith